Uropathy Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The market is segmented By Treatment (Devices (Catheters, Stents, Other Devices), and Drugs), End-user and Geography.

Uropathy Treatment Market Size

Single User License


Team License


Corporate License


Book before:
obstructive uropathy treatment 1
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 4.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Uropathy Treatment Market

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License


Book before:

Uropathy Treatment Market Analysis

The Uropathy Treatment Market is expected to register a CAGR of 4.2% during the forecast period. Uropathy/obstructive uropathy may occur due to kidney stones, bladder stones, blood clots, uterine cancer, colon cancer, cervical cancer, and problems with the nerves that supply the bladder. Treatment available for management of uropathy includes stents, catheters and drugs.

According to a study published in Advances in Urology, Kidney stone disease is an increasing urological disorder of human health which is affecting about 15% of the world population and it affects all age groups but occurs more frequently in men than in women within the age of 20-49 years. Moreover, during lifetime, approximately 7% of women and 13% of men will develop a kidney stone.

Increasing prevalence of kidney stone, urological disorders and rising incidence of cancer and technological advancement in catheters and stents are the key driving factors in uropathy treatment market.

Uropathy Treatment Market Trends

This section covers the major market trends shaping the Uropathy Treatment Market according to our research experts:

Stents Segment is Expected to Hold a Major Market Share in the Uropathy Treatment Market

  • A stent is a thin tube used to prevent or treat a blockage that prevents the flow of urine from the kidneys. The length of the stents used in adult patients varies between 24 and 30 cm. Additionally, stents come in differing gauges or diameters, to fit different size ureters.
  • According to the American Academy of Family Physicians (AAFP), Kidney stones are a common disorder, with an annual incidence of eight cases per 1,000 adults. Moreover, around 13% of men and 7% of women develop a kidney stone in their lifetime and the overall incidence of urinary retention is 4.5 to 6.8 per 1,000 men, per year, in the United States. Moreover, the stent is used when there is a blockage in the ureter (in case of kidney stones) and allows urine to drain around the blockage and also decrease the pain associated with the blockage (i.e. kidney stone). In some cases, infection associated with the kidney stone stents helps to drain the infected urine. 
  • Stents segment holds a significant market share in the uropathy treatment market and is anticipated to show a similar trend over the forecast period due to the availability of specific product types according to the requirements.
  • Increasing prevalence of urological disorders and technological advancement in the material used for stents are the key driving factors in the stents segment.
Obstructive Uropathy Treatment key trend 1.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global uropathy treatment market due to increasing prevalence of kidney stones in this region. According to a study published in the Clinical Journal of the American Society of Nephrology, in the United States, 1 in 11 individuals will experience a urinary stone in their lifetime. In addition, the frequency of urinary stone disease (USD) in children is increasing (4%-6%) yearly, particularly among adolescents. Furthermore, the increase in technological advancements and new product launches, and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Obstructive Uropathy Treatment Market 2

Uropathy Treatment Industry Overview

The Uropathy Treatment Market is fragmented competitive and consists of several major players. Some of the leading companies operating in the market include Boston Scientific Corporation, Cook Medical, Bayer AG, Sanofi, B. Braun Melsungen AG, C. R. Bard, Inc, Olympus Corporation, Teleflex Incorporated, Merit Medical Systems, Inc and Argon Medical Devices, Inc.

Uropathy Treatment Market Leaders

  1. Boston Scientific Corporation

  2. B. Braun Melsungen AG

  3. Cook Medical

  4. Bayer AG

  5. Sanofi

*Disclaimer: Major Players sorted in no particular order

CP Uropathy.png
Need More Details on Market Players and Competitors?
Download PDF

Uropathy Treatment Market Report - Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Urological Disorders

      2. 4.2.2 Technological Advancement in the Material Used for Catheters and Stents

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Infection due to Stents and Catheters

      2. 4.3.2 Discomfort and Pain due to Stents and Catheters

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Treatment

      1. 5.1.1 Devices

        1. Catheters

        2. Stents

        3. Other Devices

      2. 5.1.2 Drugs

    2. 5.2 End-user

      1. 5.2.1 Hospitals and Clinics

      2. 5.2.2 Ambulatory Surgical Centre

      3. 5.2.3 Other End-users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Cook Medical

      3. 6.1.3 Bayer AG

      4. 6.1.4 Sanofi

      5. 6.1.5 B. Braun Melsungen AG

      6. 6.1.6 C. R. Bard, Inc

      7. 6.1.7 Olympus Corporation

      8. 6.1.8 Teleflex Incorporated

      9. 6.1.9 Merit Medical Systems, Inc

      10. 6.1.10 Argon Medical Devices, Inc

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Uropathy Treatment Industry Segmentation

As per the scope of the report, Uropathy is a disease of the urinary or urogenital organs that may result in the urinary related problems. Urinary system related problems include conditions such as kidney failure, urinary tract infections, kidney stones, prostate enlargement, and bladder control problems. Uropathy Treatment Market is segmented By Treatment type, End-user and Geography.

By Treatment
Other Devices
Hospitals and Clinics
Ambulatory Surgical Centre
Other End-users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America
Need A Different Region Or Segment?
Customize Now

Uropathy Treatment Market Research FAQs

The Uropathy Treatment Market is projected to register a CAGR of 4.20% during the forecast period (2024-2029)

Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Bayer AG and Sanofi are the major companies operating in the Uropathy Treatment Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Uropathy Treatment Market.

The report covers the Uropathy Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Uropathy Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Uropathy Treatment Industry Report

Statistics for the 2024 Uropathy Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Uropathy Treatment analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Uropathy Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)